Bruce C. Cozadd
2011
In 2011, Bruce C. Cozadd earned a total compensation of $3.6M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 86% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $552,000 |
|---|---|
| Option Awards | $2,474,780 |
| Salary | $563,173 |
| Other | $1,710 |
| Total | $3,591,663 |
Cozadd received $2.5M in option awards, accounting for 69% of the total pay in 2011.
Cozadd also received $552K in non-equity incentive plan, $563.2K in salary and $1.7K in other compensation.
Rankings
In 2011, Bruce C. Cozadd's compensation ranked 1,693rd out of 10,747 executives tracked by ExecPay. In other words, Cozadd earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,693 out of 10,747 | 84th |
Division Manufacturing | 616 out of 3,958 | 84th |
Major group Chemicals And Allied Products | 133 out of 1,034 | 87th |
Industry group Drugs | 74 out of 782 | 91st |
Industry Pharmaceutical Preparations | 62 out of 567 | 89th |
Source: SEC filing on June 12, 2014.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2011.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019